Thieno[2,3-c] isoquinolines for use as inhibitors of PARP
申请人:Pellicciari Roberto
公开号:US20060094746A1
公开(公告)日:2006-05-04
The present invention relates to compounds for the inhibition of poly(ADP-ribose) polymerase (PARP). In some embodiments, the compounds have the Formula:
wherein the constituent variables are as defined herein. The invention further provides methods for the use of the compounds disclosed herein.
THIENO[2,3-C] ISOQUINOLINES FOR USE AS INHIBITORS OF PARP
申请人:PELLICCIARI ROBERTO
公开号:US20110237617A1
公开(公告)日:2011-09-29
The present invention relates to compounds for the inhibition of poly(ADP-ribose) polymerase (PARP). In some embodiments, the compounds have the Formula:
wherein the constituent variables are as defined herein. The invention further provides methods for the use of the compounds disclosed herein.
Thieno[2,3-c]iosquinolines for use as inhibitors of PARP
申请人:——
公开号:US06989388B2
公开(公告)日:2006-01-24
The present invention relates to compounds for the inhibition of poly(ADP-ribose) polymerase (PARP). In some embodiments, the compounds have the Formula:
wherein the constituent variables are as defined herein. The invention further provides methods for the use of the compounds disclosed herein.
Thieno(2,3-C) Isoquinolines for use as inhibitors of Parp
申请人:SMITHKLINE BEECHAM PLC
公开号:EP1464646A1
公开(公告)日:2004-10-06
Heterocyclic derivatives, including derivatives of thieno[2,3-c]isoquinolin-3-one and their use in therapy as inhibitors of poly(ADP-ribose) polymerase (PARP), for use in the prevention and treatment of tissue damage due to ischaemia and reperfusion, degenerative diseases, inflammatory diseases, tumour diseases, leukaemia and/or sarcoma.